|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.622
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.586
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.580
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.570
|
|
|
|
positive regulation of skeletal muscle fiber development
|
GO:0048743 |
3 |
0.537
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.504
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.426
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.394
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.329
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.324
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.324
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.319
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.302
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.292
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.283
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.280
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.256
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.252
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.244
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.238
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.234
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.230
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.228
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.216
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.212
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.199
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.194
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.190
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.188
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.169
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.168
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.166
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.164
|
|
|
|
skeletal muscle fiber adaptation
|
GO:0043503 |
1 |
0.156
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.153
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.149
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.149
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.148
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.147
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.145
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.140
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.138
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.135
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.134
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.133
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.133
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.130
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.119
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.118
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.115
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.115
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.114
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.114
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.106
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.104
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.104
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.104
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.103
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.102
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.097
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.097
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.097
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.096
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.096
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.095
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.095
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.095
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.093
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.093
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.093
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.091
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.090
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.090
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.090
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.088
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.087
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.087
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.087
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.086
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.086
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.085
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.085
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.084
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.083
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.083
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.083
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.082
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.082
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.081
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.079
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.079
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.079
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.078
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.078
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.077
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.077
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.077
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.077
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.077
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.076
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.076
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.076
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.076
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.075
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.075
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.075
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.075
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.075
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.074
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.073
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.072
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.071
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.071
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.071
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.070
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.070
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.069
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.069
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.069
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.068
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.068
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.067
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.066
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.066
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.066
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.064
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.064
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.064
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.064
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.063
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.063
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.062
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.062
|
|
|
|
striated muscle atrophy
|
GO:0014891 |
2 |
0.062
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.062
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.061
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.061
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.061
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.061
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.061
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.060
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.060
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.060
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.060
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.059
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.059
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.058
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.058
|
|
|
|
positive regulation of muscle adaptation
|
GO:0014744 |
2 |
0.058
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.058
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.057
|
|
|
|
myotube differentiation involved in skeletal muscle regeneration
|
GO:0014908 |
2 |
0.057
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.057
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.057
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.056
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.056
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.056
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.055
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.055
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.054
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.054
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.054
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.054
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.054
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.053
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.053
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.052
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.052
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.052
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.052
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.051
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.051
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.051
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.051
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.051
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.050
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.050
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.050
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.050
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.049
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.049
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.049
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.049
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.049
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.049
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.048
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.048
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.048
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.048
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.048
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.048
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.048
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.047
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.047
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.047
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.047
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.046
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.046
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.046
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.046
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.045
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.045
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.045
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.045
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.044
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.044
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.044
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.044
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.044
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.044
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.044
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.044
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.043
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.043
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.043
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.043
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.043
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.043
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.043
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.042
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.042
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.041
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.041
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.041
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.041
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.040
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.040
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.040
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.040
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.040
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.040
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.040
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.040
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.040
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.039
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.039
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.039
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.039
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.039
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.039
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.039
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.039
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.039
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.038
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.038
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.038
|
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.038
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.038
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.038
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.038
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.038
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.037
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.037
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.037
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.037
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.037
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.037
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.037
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.037
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.037
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.037
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.036
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.036
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.036
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.036
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.036
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.036
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.035
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.035
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.035
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.035
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.035
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.035
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.035
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.034
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.034
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.034
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.034
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.034
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.034
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.034
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.034
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.034
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.034
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.034
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.034
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.033
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.033
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.033
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.033
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.033
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.033
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.033
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.033
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.033
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.032
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.032
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.032
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.032
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.032
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.032
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.032
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.032
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.032
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.032
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.032
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.032
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.032
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.032
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.031
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.031
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.031
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.031
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.031
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.031
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.030
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.030
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.030
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.030
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.030
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.030
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.030
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.030
|
|
|
|
regulation of circadian sleep wake cycle rem sleep
|
GO:0042320 |
1 |
0.030
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.030
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.030
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.030
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.030
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.029
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.029
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.029
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.029
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.029
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.029
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.029
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.028
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.028
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.028
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.028
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.028
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.028
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.028
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.028
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.027
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.027
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.027
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.027
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.027
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.027
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.027
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.027
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.027
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.027
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.027
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.026
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.026
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.026
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
2 |
0.026
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.026
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.026
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.026
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.026
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.026
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.026
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.025
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.025
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.025
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.025
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.025
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.025
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.025
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.025
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.025
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.025
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.025
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.025
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.024
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.024
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.024
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.024
|
|
|
|
positive regulation of myoblast differentiation
|
GO:0045663 |
8 |
0.024
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.024
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.024
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.024
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.024
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.024
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.024
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.024
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.024
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.024
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.024
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.024
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.024
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.023
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.023
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.023
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.023
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.023
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.023
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.023
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.023
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.023
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.023
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.023
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.023
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.023
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.023
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.022
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.022
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.022
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.022
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.022
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.022
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.022
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.022
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.022
|
|
|
|
negative regulation of action potential
|
GO:0045759 |
1 |
0.022
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.022
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.022
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.022
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.022
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.022
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.022
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.022
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.022
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.022
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.021
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.021
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.021
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.021
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.021
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.021
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.021
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.021
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.021
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.021
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.021
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.020
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.020
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.020
|
|
|
|
mammary gland specification
|
GO:0060594 |
4 |
0.020
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.020
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.020
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.020
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.020
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.020
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.020
|
|
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.020
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.020
|
|
|
|
somite specification
|
GO:0001757 |
4 |
0.020
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.020
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.020
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.020
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.020
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.020
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.020
|
|
